Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2015 14:05 ET | Source: ProLynx Inc.

ProLynx Announces Active IND of a Novel Ultra-Long Acting PEG–SN-38 Conjugate to Treat Solid Tumors

SAN FRANCISCO, June 02, 2015 (GLOBE NEWSWIRE) -- ProLynx LLC announced today that an Investigational New Drug (IND) application for their novel, ultra-long acting PEG~SN-38 (PLX-0264; DFP-13318)...